Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor–Naïve Myelofibrosis: Phase III SENTRY TrialPrithviraj Bose, Nauman Butt, Haifa Kathrin Al-Ali et al.|Journal of Clinical Oncology|2026Cited by 1